class="wp-theme-Newspaper supp-body td-standard-pack global-block-template-1 tdc-header-template tdc-footer-template td-animation-stack-type0 td-full-layout"
Same general cautions as calcium supplementation. Phosphorus load: relevant in chronic kidney disease (CKD) — avoid or limit in CKD. Drug interactions: reduces absorption of fluoroquinolone and tetracycline antibiotics, iron, and thyroxine — separate by 2 hours.
Calcium phosphate salt used as tablet diluent, filler, and calcium/phosphorus supplement. E341. Widely used as the primary tablet filler in pharmaceutical manufacturing. Provides calcium and phosphate.
Acts on cellular signalling pathways relevant to the documented clinical indications. Contains bioactive compounds with enzyme-modulating, receptor-binding, or antioxidant properties studied in peer-reviewed literature.
| Population | Safety rating | Max safe dose |
|---|---|---|
| General | Possibly safe | — |
| Pregnancy | Possibly safe | — |
| Elderly | Possibly safe | — |
No peer-reviewed clinical trial data found for this ingredient.
Data by supplement.ge — Public Health Institute of Georgia (PHIG)